Opdivo (nivolumab)

pCPA File Number: 20880

Negotiation Status:

Concluded with an LOI

Indication(s):

Non-small Cell Lung Cancer

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CDA-AMC Project Number:

PC0069-000

pCPA Engagement Letter Issued:

2016-07-04

Negotiation Process Concluded:

2017-01-20